
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $4.2B | -- | -- | $0.45 | -- |
07/30/2025 | Q2 | $4.3B | -- | -- | $0.53 | -- |
04/30/2025 | Q1 | $4.3B | $4.3B | $0.51 | $0.46 | $0.05 |
02/12/2025 | Q4 | $4.3B | $4.3B | $0.52 | $0.34 | $0.18 |
10/30/2024 | Q3 | $4.2B | $4.2B | $0.61 | $0.61 | $0.00 |
07/31/2024 | Q2 | $4.2B | $4.3B | $0.60 | $0.59 | $0.01 |
05/01/2024 | Q1 | $4.2B | $4.4B | $0.67 | $0.58 | $0.09 |
02/13/2024 | Q4 | $4.1B | $4.4B | $0.91 | $0.71 | $0.20 |
11/08/2023 | Q3 | $3.9B | $4B | $0.46 | $0.49 | -$0.03 |
08/02/2023 | Q2 | $3.8B | $3.9B | $0.55 | $0.52 | $0.03 |
05/01/2023 | Q1 | -- | $3.9B | $1.24 | -- | -- |
02/08/2023 | Q4 | -- | $3.6B | $0.69 | -- | -- |
11/02/2022 | Q3 | -- | $3.4B | -$1.45 | -- | -- |
08/03/2022 | Q2 | -- | $3.3B | $4.20 | -- | -- |
05/02/2022 | Q1 | -- | $2.9B | -$0.06 | -- | -- |
02/09/2022 | Q4 | -- | $3.1B | $0.23 | -- | -- |
11/03/2021 | Q3 | -- | $2.7B | $2.77 | -- | -- |
08/04/2021 | Q2 | -- | $2.3B | $0.14 | -- | -- |
04/28/2021 | Q1 | -- | $1.6B | -$0.69 | -- | -- |
02/10/2021 | Q4 | -- | $1.5B | -$0.92 | -- | -- |
10/29/2020 | Q3 | -- | $1.1B | -$1.08 | -- | -- |
07/30/2020 | Q2 | -- | $289.8M | -$1.67 | -- | -- |
04/30/2020 | Q1 | -- | $2.3B | $1.64 | -- | -- |
02/12/2020 | Q4 | -- | $3.2B | $3.91 | -- | -- |
10/30/2019 | Q3 | -- | $3.3B | -$0.08 | -- | -- |
07/25/2019 | Q2 | -- | $3.2B | $0.08 | -- | -- |
04/29/2019 | Q1 | -- | $3.2B | $0.05 | -- | -- |
02/13/2019 | Q4 | -- | $3.1B | -$0.06 | -- | -- |
10/30/2018 | Q3 | -- | $3B | $0.26 | -- | -- |
08/02/2018 | Q2 | -- | $2.9B | $0.21 | -- | -- |
04/26/2018 | Q1 | -- | $2.8B | $0.38 | -- | -- |
02/20/2018 | Q4 | -- | $2.6B | $2.42 | -- | -- |
11/08/2017 | Q3 | -- | $2.8B | $0.26 | -- | -- |
07/27/2017 | Q2 | -- | $2.7B | $0.36 | -- | -- |
04/27/2017 | Q1 | -- | $2.7B | $0.36 | -- | -- |
02/16/2017 | Q4 | -- | $2.5B | $0.04 | -- | -- |
11/07/2016 | Q3 | -- | $2.5B | $0.93 | -- | -- |
08/04/2016 | Q2 | -- | $2.3B | $0.83 | -- | -- |
05/05/2016 | Q1 | -- | $2.2B | $0.12 | -- | -- |
02/18/2016 | Q4 | -- | $2.2B | -$1.38 | -- | -- |
10/29/2015 | Q3 | -- | $2.3B | $0.12 | -- | -- |
MGM Resorts International reported $4.3B worth of top line sales in its most recent quarter.
MGM Resorts International announced earnings per share of $0.51 which represents a beat of analyst forecast a $0.46 per share.
MGM Resorts International reported $2B that represents $6.77 per share over the last quarter.
MGM Resorts International's earnings are forecast to decrease from $2.40 per share to $2.43 per share next year representing a decrease of -6.13%.
MGM Resorts International's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.